{"id": "1347570036433678336", "creation": 1610120707.0, "user_id": "318097427", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 3, "quote_count": 1}}, "text": "In this @biospace article, our CEO Dan O'Connor discusses our first-in-class #COVID19 #vaccine candidate combining our DNA-based interleukin-12 platform with the SARS-CoV-2 spike protein to stimulate strong cellular &amp; humoral immune responses: https://t.co/gv9B7VpgDa", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}